CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

This is the first time Indus Towers has received a ₹575 target, making it the highest among analysts covering the telecom ...

Vikash Kumar Jain, India Strategist and Head of Research at CLSA, predicts 2025 will be a year of consolidation for Indian markets. He noted that the consolidation trend, which began in October, could ...

Newmont Corporation (NEM) stock saw a modest uptick, ending the day at $41.67 which represents a slight increase of $0.02 or 0.05% from the prior close of $41.65. The stock opened at $41.35 and ...

The brokerage firm has also added Zomato to its high conviction outperform list, saying the recent correction is a buying ...

Shares of Zomato surged as much as 7.27% to reach INR 261.75 during the intraday trading session on the BSE today (January 16 ...

CLSA has initiated coverage on Hyundai Motor India with an 'Outperform' rating and a target price of Rs 2,155, citing strong ...

India's most valued company, Reliance Industries Ltd (RIL), reported a robust performance in the third quarter of the current ...

Analysts have mixed views on TCS following its Q3FY25 performance, with several brokerages highlighting the company's growth ...